SEDOR PHARMACEUTICALS focuses on investment growth and revitalization opportunities in the pharmaceuticals and biologics sector. Headed by John Sedor, a veteran with over 30 years of experience in the healthcare industry, SEDOR PHARMACEUTICALS identifies and procures pharmaceuticals and biologics companies and assets. The team applies its extensive expertise in development, operations, manufacturing, and commercialization to enhance value for investors. SEDOR PHARMACEUTICALS has licensed three clinical-stage compounds to establish its specialty pharmaceutical platform and has recently submitted for FDA approval on its primary injectable compound, CE-Fosphenytoin, designed for treatment.